OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
A Renaissance for Oncolytic Adenoviruses?
Paola Blanchette, Jose G. Teodoro
Viruses (2023) Vol. 15, Iss. 2, pp. 358-358
Open Access | Times Cited: 12
Paola Blanchette, Jose G. Teodoro
Viruses (2023) Vol. 15, Iss. 2, pp. 358-358
Open Access | Times Cited: 12
Showing 12 citing articles:
Immune landscape and response to oncolytic virus-based immunotherapy
Chaolong Lin, Wenzhong Teng, Tian Yang, et al.
Frontiers of Medicine (2024) Vol. 18, Iss. 3, pp. 411-429
Closed Access | Times Cited: 5
Chaolong Lin, Wenzhong Teng, Tian Yang, et al.
Frontiers of Medicine (2024) Vol. 18, Iss. 3, pp. 411-429
Closed Access | Times Cited: 5
Nanotechnology and nano-sized tools: Newer approaches to circumvent oncolytic adenovirus limitations
Maryam Mashhadi Abolghasem Shirazi, Tayebeh Azam Saedi, Zahra Samadi Moghaddam, et al.
Pharmacology & Therapeutics (2024) Vol. 256, pp. 108611-108611
Closed Access | Times Cited: 4
Maryam Mashhadi Abolghasem Shirazi, Tayebeh Azam Saedi, Zahra Samadi Moghaddam, et al.
Pharmacology & Therapeutics (2024) Vol. 256, pp. 108611-108611
Closed Access | Times Cited: 4
E4orf1: The triple agent of adenovirus – Unraveling its roles in oncogenesis, infectious obesity and immune responses in virus replication and vector therapy
Lilian Göttig, Sabrina Schreiner
Tumour Virus Research (2024) Vol. 17, pp. 200277-200277
Open Access | Times Cited: 1
Lilian Göttig, Sabrina Schreiner
Tumour Virus Research (2024) Vol. 17, pp. 200277-200277
Open Access | Times Cited: 1
Adenoviral vectors infect B lymphocytes in vivo
Paul Boucher, Samir Andrade Mendonça, Aluet Borrego Alvarez, et al.
Molecular Therapy (2023) Vol. 31, Iss. 9, pp. 2600-2611
Open Access | Times Cited: 4
Paul Boucher, Samir Andrade Mendonça, Aluet Borrego Alvarez, et al.
Molecular Therapy (2023) Vol. 31, Iss. 9, pp. 2600-2611
Open Access | Times Cited: 4
Agent-Based and Continuum Models for Spatial Dynamics of Infection by Oncolytic Viruses
David Morselli, Marcello Delitala, Federico Frascoli
Bulletin of Mathematical Biology (2023) Vol. 85, Iss. 10
Open Access | Times Cited: 4
David Morselli, Marcello Delitala, Federico Frascoli
Bulletin of Mathematical Biology (2023) Vol. 85, Iss. 10
Open Access | Times Cited: 4
A promising future in cancer immunotherapy: Oncolytic viruses
Seyed Mahmood Seyed Khorrami, Arezou Azadi, Nasrin Rastegarvand, et al.
European Journal of Pharmacology (2023) Vol. 960, pp. 176063-176063
Closed Access | Times Cited: 3
Seyed Mahmood Seyed Khorrami, Arezou Azadi, Nasrin Rastegarvand, et al.
European Journal of Pharmacology (2023) Vol. 960, pp. 176063-176063
Closed Access | Times Cited: 3
The safety and efficacy of systemic delivery of a new liver-de-targeted TGFβ signaling inhibiting adenovirus in an immunocompetent triple negative mouse mammary tumor model
Soon Cheon Shin, Renee E. Vickman, Beniamin Filimon, et al.
Cancer Gene Therapy (2024) Vol. 31, Iss. 4, pp. 574-585
Open Access
Soon Cheon Shin, Renee E. Vickman, Beniamin Filimon, et al.
Cancer Gene Therapy (2024) Vol. 31, Iss. 4, pp. 574-585
Open Access
Role of homologous recombination/recombineering on human adenovirus genome engineering: Not the only but the most competent solution
L.E.R. Dawson, Montaha Alshawabkeh, Katrin Schröer, et al.
Engineering Microbiology (2024) Vol. 4, Iss. 1, pp. 100140-100140
Open Access
L.E.R. Dawson, Montaha Alshawabkeh, Katrin Schröer, et al.
Engineering Microbiology (2024) Vol. 4, Iss. 1, pp. 100140-100140
Open Access
Deletion of RGD-motif from penton base in oncolytic adenoviruses enhances antitumor efficacy of combined CAR T cell therapy
Álvaro Morales‐Molina, Miguel Ángel Rodríguez-Milla, Patricia Garcia-Rodriguez, et al.
Deleted Journal (2024) Vol. 32, Iss. 3, pp. 200863-200863
Open Access
Álvaro Morales‐Molina, Miguel Ángel Rodríguez-Milla, Patricia Garcia-Rodriguez, et al.
Deleted Journal (2024) Vol. 32, Iss. 3, pp. 200863-200863
Open Access
Development and Characterization of an Oncolytic Human Adenovirus-Based Vector Co-Expressing the Adenovirus Death Protein and p14 Fusion-Associated Small Transmembrane Fusogenic Protein
Kathy L. Poulin, Ryan G. Clarkin, Joshua Del Papa, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 22, pp. 12451-12451
Open Access
Kathy L. Poulin, Ryan G. Clarkin, Joshua Del Papa, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 22, pp. 12451-12451
Open Access
Updates and New Perspectives on Adenoviral Gene Therapy and Vaccine Vectors
Thomas Dobner, Luca D. Bertzbach
Viruses (2023) Vol. 15, Iss. 2, pp. 514-514
Open Access
Thomas Dobner, Luca D. Bertzbach
Viruses (2023) Vol. 15, Iss. 2, pp. 514-514
Open Access
The Safety and Efficacy of Systemic Delivery of a New Liver-de-targeted TGFβ Signaling Inhibiting Adenovirus in an Immunocompetent Triple Negative Mouse Mammary Tumor Model
W. Xu, Soon Cheon Shin, Renee E. Vickman, et al.
Research Square (Research Square) (2023)
Open Access
W. Xu, Soon Cheon Shin, Renee E. Vickman, et al.
Research Square (Research Square) (2023)
Open Access
